Skip to content

Feasibility and efficacy of concentrated ERP in patients with OCD

Feasibility and efficacy of concentrated Exposure and Response Prevention therapy in patients with OCD - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094217
Enrollment
26
Registered
2025-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F422- Mixed obsessional thoughts and acts

Interventions

Intervention1: Concentrated Exposure and Response Prevention Therapy: Psychological intervention for Obsessive-Compulsive Disorder (OCD) and other anxiety disorders, where treatment is delivered in an

Sponsors

University Grants Commission
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients meeting the primary diagnosis of Obsessive Compulsive Disorder as per the diagnostic criteria of ICD-11. Y-BOCS score ranging from 16-31 (moderate-severe range) and a CGI score of 4 to 6 (moderately ill to severely ill). Able to comprehend and understand spoken English and Hindi. Patients that are drug-naive or stabilized on medication for 8 weeks prior to the inclusion in the study.

Exclusion criteria

Exclusion criteria: Severe comorbid psychiatric conditions such as high suicide risk (as determined by FLII-11), severe major depression with psychotic features, psychosis, bipolar disorder, substance dependence (other than tobacco), severe personality disorder; Clinically determined Intellectual or other developmental disability (autism) that may compromise the ability to consent and participate in CBT; Patients with any past medical history of cardiac or pulmonary issues or hypertension. Women who are pregnant will also be excluded. Patients who have received more than three sessions of CBT for OCD in the previous year.

Design outcomes

Primary

MeasureTime frame
Reduction in severity of OCD symptomsTimepoint: Reduction in severity of OCD symptoms across 4 time points i.e. at baseline, 1 week, 3 weeks and 3 months post intervention

Secondary

MeasureTime frame
reduction in anxiety & depressive symptomsTimepoint: 3 time points i.e. at baseline, 3 weeks & 3 months post intervention;cost-effectiveness of concentrated Exposure & Response Prevention TherapyTimepoint: 3 time points i.e. at baseline, 3 weeks & 3 months post intervention;The role of distress tolerance, self-efficacy, & patient?s adherence to homework as predictors of outcome in concentrated ERP.Timepoint: 3 time points i.e. at baseline, 3 weeks & 3 months post intervention

Countries

India

Contacts

Public ContactRidhima Bassi

National Institute of Mental Health and Neurosciences

ajaycog2010@gmail.com9886426548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026